Notify me when Martin Capital Partners, LLC files a new 13F portfolio report.
⭐ Subscribe ⭐| Quarter | Holdings | Value $ | Bought | Sold | Net | Top Holdings | Form Type | Filing Time |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | 70 | $265,833,000 | +$22,670,371 | -$17,870,764 | +$4,799,607 | AMGN, MSFT, ASML, CSCO, CFR | 13F-HR | 06 Jan 2026, 10:28 |
| Q3 2025 | 70 | $257,801,000 | +$22,975,164 | -$26,504,543 | -$3,529,379 | AMGN, CME, CFR, ASML, MSFT | 13F-HR | 03 Oct 2025, 17:56 |
| Q2 2025 | 75 | $255,075,000 | +$172,287,186 | -$224,000 | +$172,063,186 | JPM, CME, CFR, AMGN, ETR | 13F-HR | 08 Jul 2025, 13:54 |
| Q1 2025 | 58 | $83,618,000 | +$3,340,618 | -$5,894,200 | -$2,553,582 | SPSB, IGSB, AMGN, JPM, ETR | 13F-HR | 15 Apr 2025, 13:49 |
| Q4 2024 | 58 | $84,293,000 | +$6,137,000 | -$111,109,387 | -$104,972,387 | SPSB, IGSB, CFR, JPM, SHY | 13F-HR | 27 Jan 2025, 12:17 |
| Q3 2024 | 69 | $202,380,000 | +$7,323,821 | -$69,182,684 | -$61,858,863 | ETR, AMGN, VZ, TXN, CFR | 13F-HR | 15 Oct 2024, 10:23 |
| Q2 2024 | 71 | $247,575,000 | +$1,863,504 | -$8,324,124 | -$6,460,620 | UL, GD, AMGN, TXN, JPM | 13F-HR | 15 Jul 2024, 14:33 |
| Q1 2024 | 69 | $260,749,000 | +$16,303,377 | -$12,564,516 | +$3,738,861 | MRK, GD, CFR, UL, VZ | 13F-HR | 05 Apr 2024, 14:03 |
| Q4 2023 | 70 | $245,307,000 | +$11,213,293 | -$18,074,224 | -$6,860,931 | JPM, AMGN, CFR, GD, MSM | 13F-HR | 05 Jan 2024, 18:41 |
| Q3 2023 | 72 | $237,633,000 | +$4,428,334 | -$5,504,979 | -$1,076,645 | JPM, UL, AMGN, MSM, CMCSA | 13F-HR | 13 Oct 2023, 13:14 |
| Q2 2023 | 72 | $246,281,000 | +$13,167,100 | -$9,280,289 | +$3,886,811 | UL, JPM, MRK, JNJ, MSM | 13F-HR | 17 Jul 2023, 15:35 |
| Q1 2023 | 70 | $240,430,000 | +$27,318,841 | -$26,026,803 | +$1,292,038 | UL, JPM, TXN, MRK, VZ | 13F-HR | 05 Apr 2023, 16:48 |
| Q4 2022 | 71 | $242,300,000 | +$8,751,612 | -$10,373,763 | -$1,622,151 | PFE, UL, XOM, MRK, JPM | 13F-HR | 05 Jan 2023, 14:43 |
| Q3 2022 | 77 | $215,683,000 | +$25,221,411 | -$3,815,234 | +$21,406,177 | PFE, UL, JNJ, XOM, AMGN | 13F-HR | 06 Oct 2022, 13:18 |
| Q2 2022 | 71 | $210,764,000 | +$12,138,777 | -$3,893,989 | +$8,244,788 | PFE, UL, JNJ, VZ, AMGN | 13F-HR | 08 Jul 2022, 12:56 |
| Q1 2022 | 70 | $219,032,000 | +$15,288,561 | -$9,576,452 | +$5,712,109 | CVX, PFE, JNJ, GD, JPM | 13F-HR | 06 Apr 2022, 11:01 |
| Q4 2021 | 69 | $211,842,000 | +$5,677,842 | -$4,295,563 | +$1,382,279 | PFE, JPM, CSCO, TXN, JNJ | 13F-HR | 06 Jan 2022, 18:17 |
| Q3 2021 | 68 | $198,006,000 | +$4,271,756 | -$1,524,860 | +$2,746,896 | PFE, JPM, USB, INTC, TXN | 13F-HR | 06 Oct 2021, 12:16 |
| Q2 2021 | 68 | $197,229,000 | +$6,105,196 | -$2,961,529 | +$3,143,667 | JPM, PFE, TXN, USB, JNJ | 13F-HR | 06 Jul 2021, 15:53 |
| Q1 2021 | 69 | $188,392,000 | +$13,839,747 | -$8,482,278 | +$5,357,469 | JPM, PFE, TXN, USB, JNJ | 13F-HR | 14 Apr 2021, 12:18 |
| Q4 2020 | 67 | $171,127,000 | +$10,220,998 | -$3,447,036 | +$6,773,962 | TXN, PFE, JPM, JNJ, MSM | 13F-HR | 07 Jan 2021, 13:54 |
| Q3 2020 | 63 | $149,500,000 | +$14,357,059 | -$9,857,254 | +$4,499,805 | UPS, PFE, AMGN, TXN, JNJ | 13F-HR | 07 Oct 2020, 18:00 |
| Q2 2020 | 60 | $142,158,000 | +$10,870,826 | -$14,444,416 | -$3,573,590 | PFE, UPS, AMGN, JNJ, MSFT | 13F-HR | 07 Jul 2020, 15:43 |
| Q1 2020 | 58 | $131,272,000 | +$19,985,167 | -$26,163,032 | -$6,177,865 | PFE, JNJ, AMGN, UPS, GILD | 13F-HR | 21 Apr 2020, 15:29 |
| Q4 2019 | 62 | $169,199,000 | +$21,894,797 | -$8,839,439 | +$13,055,358 | PFE, JPM, JNJ, AMGN, CVX | 13F-HR | 31 Jan 2020, 16:23 |
| Q3 2019 | 53 | $148,583,000 | +$18,127,070 | -$13,465,493 | +$4,661,577 | PFE, JNJ, GSK, JPM, AAPL | 13F-HR | 20 Nov 2019, 12:37 |
| Q2 2019 | 50 | $141,354,000 | +$12,347,921 | -$5,570,186 | +$6,777,735 | PFE, JNJ, CSCO, SBUX, GSK | 13F-HR | 12 Aug 2019, 14:36 |
| Q1 2019 | 61 | $129,547,000 | +$18,875,266 | -$7,338,448 | +$11,536,818 | PFE, JNJ, CSCO, GSK, SBUX | 13F-HR | 07 May 2019, 18:19 |
| Q4 2018 | 49 | $108,360,000 | +$12,358,056 | -$7,557,548 | +$4,800,508 | PFE, SBUX, JNJ, PG, AMGN | 13F-HR | 13 Feb 2019, 17:55 |
| Q3 2018 | 58 | $111,624,000 | +$10,068,582 | -$2,427,324 | +$7,641,258 | PFE, JNJ, AAPL, CSCO, AMGN | 13F-HR | 14 Nov 2018, 17:06 |
| Q2 2018 | 45 | $96,933,000 | +$5,153,585 | -$8,782,975 | -$3,629,390 | PFE, JNJ, GSK, RDSB, CVX | 13F-HR | 13 Aug 2018, 17:23 |
| Q1 2018 | 44 | $100,452,000 | +$8,370,999 | -$1,706,753 | +$6,664,246 | CSCO, PFE, JNJ, GSK, AAPL | 13F-HR | 14 May 2018, 14:02 |
| Q4 2017 | 44 | $96,343,000 | $0 | $0 | $0 | JNJ, CSCO, PFE, BA, AAPL | 13F-HR | 13 Feb 2018, 12:40 |